Literature DB >> 19438904

Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease.

Li-qun Gu1, Wei Zhu, Shuang-xia Zhao, Lin Zhao, Min-jia Zhang, Bin Cui, Huai-dong Song, Guang Ning, Yong-ju Zhao.   

Abstract

OBJECTIVE: Graves' disease (GD) is an organ-specific autoimmune disorder. Both immune-modulating genes and thyroid-specific genes are involved in its genetic pathogenesis. It remains unclear, however, how the interactions of various susceptibility genes contribute to the pathogenesis and clinical severity of the disease. The purpose of this study was to investigate the relationships between GD and single nucleotide polymorphisms (SNPs) from CTLA-4, PTPN22, PTPN12, FCRL3 (general autoimmunity genes regulating T and B cells) and the TSHR and Tg genes (disease-specific genes). Furthermore, we evaluated the influences these SNPs have on the risk and severity of GD. DESIGN AND METHODS: This cross-sectional clinical study was performed in 436 GD patients and 316 healthy, gender-matched individuals. Twenty-eight SNPs from CTLA-4, PTPN22, PTPN12, FCRL3, TSHR and Tg genes were genotyped and their associations with the risk and severity of GD were analysed.
RESULTS: The CTLA-4 rs231779, Tg rs2069550 and PTPN22 rs3789604 SNPs were associated with GD, with additive risk effects present in rs231779 and rs2069550. The ACACC and ACGCT haplotypes, composed of five SNPs in the CTLA-4 gene (rs4553808, rs5472909, rs231775, rs231777 and rs231779), were protective and risk haplotypes respectively. The AA genotype of PTPN22 rs3789604 and AA genotype of FCRL3 rs7528684 were correlated with a reduced risk of GD, while the CC genotype of TSHR rs2239610 was associated with higher serum concentrations of FT4 and TRAb. Logistic analysis confirmed the contribution of CTLA-4 rs231779 to the development of GD.
CONCLUSIONS: These preliminary results demonstrate that the immune-regulatory gene CTLA-4 and the thyroid-specific gene Tg contribute to the risk of Graves' disease with additive effects, while PTPN22 rs3789604 and FCRL3 rs7528684 polymorphisms are protective against the disease. In addition, the TSHR rs2239610 SNP is related to the severity of Graves' disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19438904     DOI: 10.1111/j.1365-2265.2009.03617.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  32 in total

1.  Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy.

Authors:  Xiaoming Yin; Rauf Latif; Rebecca Bahn; Terry F Davies
Journal:  Thyroid       Date:  2012-06-04       Impact factor: 6.568

2.  Associations between autoimmune thyroid disease prognosis and functional polymorphisms of susceptibility genes, CTLA4, PTPN22, CD40, FCRL3, and ZFAT, previously revealed in genome-wide association studies.

Authors:  Naoya Inoue; Mikio Watanabe; Hiroya Yamada; Kazuya Takemura; Fumiaki Hayashi; Noriko Yamakawa; Maiko Akahane; Yu Shimizuishi; Yoh Hidaka; Yoshinori Iwatani
Journal:  J Clin Immunol       Date:  2012-06-17       Impact factor: 8.317

Review 3.  Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.

Authors:  Yao Wang; Terry J Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-20       Impact factor: 4.799

4.  RNASET2, GPR174, and PTPN22 gene polymorphisms are related to the risk of liver damage associated with the hyperthyroidism in patients with Graves' disease.

Authors:  Qing Zhang; Shaozheng Liu; Yanxing Guan; Qingjie Chen; Qing Zhang; Xiang Min
Journal:  J Clin Lab Anal       Date:  2017-05-31       Impact factor: 2.352

5.  Identification of susceptibility SNPs in CTLA-4 and PTPN22 for scleritis in Han Chinese.

Authors:  F Li; X Ma; L Du; L Shi; Q Cao; N Li; T Pang; Y Liu; A Kijlstra; P Yang
Journal:  Clin Exp Immunol       Date:  2019-04-16       Impact factor: 4.330

6.  The influence of the genetic and non-genetic factors on bone mineral density and osteoporotic fractures in Chinese women.

Authors:  Yan-Hua Deng; Lin Zhao; Min-Jia Zhang; Chun-Ming Pan; Shuang-Xia Zhao; Hong-Yan Zhao; Li-Hao Sun; Bei Tao; Huai-Dong Song; Wei-Qing Wang; Guang Ning; Jian-Min Liu
Journal:  Endocrine       Date:  2012-07-14       Impact factor: 3.633

7.  Association of polymorphisms of rs179247 and rs12101255 in thyroid stimulating hormone receptor intron 1 with an increased risk of Graves' disease: A meta-analysis.

Authors:  Jing Gong; Shu-Jun Jiang; Ding-Kun Wang; Hui Dong; Guang Chen; Ke Fang; Jin-Rui Cui; Fu-Er Lu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-28

8.  Association study between polymorphisms of CD28, CTLA4 and ICOS and non-segmental vitiligo in a Korean population.

Authors:  Min Kyung Shin; So Hee Im; Hae Jeong Park; Su Kang Kim; Sung Vin Yim; Joo-Ho Chung; Mu-Hyoung Lee
Journal:  Exp Ther Med       Date:  2011-08-03       Impact factor: 2.447

9.  Association of the CTLA4 gene with Graves' disease in the Chinese Han population.

Authors:  Shuang-Xia Zhao; Chun-Ming Pan; Huang-Ming Cao; Bing Han; Jing-Yi Shi; Jun Liang; Guan-Qi Gao; Yong-De Peng; Qing Su; Jia-Lun Chen; Jia-Jun Zhao; Huai-Dong Song
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

Review 10.  Tyrosine phosphatase PTPN22: multifunctional regulator of immune signaling, development, and disease.

Authors:  Nunzio Bottini; Erik J Peterson
Journal:  Annu Rev Immunol       Date:  2013-12-18       Impact factor: 28.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.